Liu Caiyun, Yu Haixin, Li Zhengchao, Chen Shulian, Li Xiaoyin, Chen Xuyi, Chen Bo
School of Acupuncture & Moxibustion and Tuina; Research Center of Experimental Acupucture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China;, China.
Characteristic Medical Center of Chinese People's Armed Police Force, Tianjin, China.
Neural Regen Res. 2024 Jan;19(1):22-28. doi: 10.4103/1673-5374.375305.
Spinal cord injury is a serious disease of the central nervous system involving irreversible nerve injury and various organ system injuries. At present, no effective clinical treatment exists. As one of the artificial hibernation techniques, mild hypothermia has preliminarily confirmed its clinical effect on spinal cord injury. However, its technical defects and barriers, along with serious clinical side effects, restrict its clinical application for spinal cord injury. Artificial hibernation is a future-oriented disruptive technology for human life support. It involves endogenous hibernation inducers and hibernation-related central neuromodulation that activate particular neurons, reduce the central constant temperature setting point, disrupt the normal constant body temperature, make the body "adapt" to the external cold environment, and reduce the physiological resistance to cold stimulation. Thus, studying the artificial hibernation mechanism may help develop new treatment strategies more suitable for clinical use than the cooling method of mild hypothermia technology. This review introduces artificial hibernation technologies, including mild hypothermia technology, hibernation inducers, and hibernation-related central neuromodulation technology. It summarizes the relevant research on hypothermia and hibernation for organ and nerve protection. These studies show that artificial hibernation technologies have therapeutic significance on nerve injury after spinal cord injury through inflammatory inhibition, immunosuppression, oxidative defense, and possible central protection. It also promotes the repair and protection of respiratory and digestive, cardiovascular, locomotor, urinary, and endocrine systems. This review provides new insights for the clinical treatment of nerve and multiple organ protection after spinal cord injury thanks to artificial hibernation. At present, artificial hibernation technology is not mature, and research faces various challenges. Nevertheless, the effort is worthwhile for the future development of medicine.
脊髓损伤是一种严重的中枢神经系统疾病,涉及不可逆的神经损伤和各种器官系统损伤。目前,尚无有效的临床治疗方法。作为人工冬眠技术之一,轻度低温已初步证实其对脊髓损伤的临床疗效。然而,其技术缺陷和障碍以及严重的临床副作用限制了其在脊髓损伤临床中的应用。人工冬眠是一项面向未来的人类生命支持颠覆性技术。它涉及内源性冬眠诱导剂和与冬眠相关的中枢神经调节,可激活特定神经元,降低中枢恒温设定点,扰乱正常的恒定体温,使身体“适应”外部寒冷环境,并降低对冷刺激的生理抵抗力。因此,研究人工冬眠机制可能有助于开发比轻度低温技术的降温方法更适合临床应用的新治疗策略。本文综述介绍了人工冬眠技术,包括轻度低温技术、冬眠诱导剂和与冬眠相关的中枢神经调节技术。总结了低温和冬眠对器官和神经保护的相关研究。这些研究表明,人工冬眠技术通过抑制炎症、免疫抑制、氧化防御和可能的中枢保护作用,对脊髓损伤后的神经损伤具有治疗意义。它还促进呼吸、消化、心血管、运动、泌尿和内分泌系统的修复和保护。本文综述为人工冬眠在脊髓损伤后神经和多器官保护的临床治疗提供了新的见解。目前,人工冬眠技术尚不成熟,研究面临各种挑战。尽管如此,为了医学的未来发展,这种努力是值得的。